Arkolith/Insider Trading/MIRA/Form 4

Aminov Erez

Chief Executive Officer, DirectorMIRA PHARMACEUTICALS, INC. (MIRA) · full profile →Form 4 · filed Nov 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$134K
Net Open-Market Flow
-$134K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2024Sell(S)45K$1.27$57K1.1M
Nov 19, 2024Sell(S)55K$1.39$77K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-047998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML